STOK
Stoke Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$29.81
−0.60%0
Insider buys (3m)
13
Insider sells (3m)
-$1.3M
Net value (3m)
-1.5%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 3, 2026 | Ticho Barry · officer: CHIEF MEDICAL OFFICER | Sale | 3,945 | $31 |
| Sep 3, 2026 | Ticho Barry · officer: CHIEF MEDICAL OFFICER | Sale | 1,600 | $31 |
| Aug 18, 2026 | Kaye Edward M. MD · director | Sale | 637 | $32 |
| Aug 18, 2026 | Allan Jonathan · officer: GENERAL COUNSEL & CORP SEC | M-Exempt | 6,000 | $0.00 |
| Aug 18, 2026 | Kaye Edward M. MD · director | M-Exempt | 26,250 | $0.00 |
| Aug 18, 2026 | Ticho Barry · officer: CHIEF MEDICAL OFFICER | Sale | 4,525 | $32 |
| Aug 18, 2026 | Kaye Edward M. MD · director | Sale | 11,930 | $32 |
| Aug 18, 2026 | Allan Jonathan · officer: GENERAL COUNSEL & CORP SEC | Sale | 145 | $32 |
| Aug 18, 2026 | Ticho Barry · officer: CHIEF MEDICAL OFFICER | M-Exempt | 10,000 | $0.00 |
| Aug 18, 2026 | Ticho Barry · officer: CHIEF MEDICAL OFFICER | Sale | 242 | $32 |
| Aug 18, 2026 | Allan Jonathan · officer: GENERAL COUNSEL & CORP SEC | Sale | 2,716 | $32 |
| Aug 5, 2026 | Ticho Barry · officer: CHIEF MEDICAL OFFICER | Sale | 1,269 | $29 |
| Aug 5, 2026 | Ticho Barry · officer: CHIEF MEDICAL OFFICER | Sale | 5,907 | $29 |
| Jul 17, 2026 | McCauley Thomas · officer: Chief Scientific Officer | A-Award | 225,000 | $30 |
| Jul 6, 2026 | Ticho Barry · officer: CHIEF MEDICAL OFFICER | Sale | 500 | $33 |
| Jul 6, 2026 | Ticho Barry · officer: CHIEF MEDICAL OFFICER | Sale | 6,728 | $33 |
| Jun 18, 2026 | Allan Jonathan · officer: GENERAL COUNSEL & CORP SEC | Sale | 1,457 | $30 |
| Jun 5, 2026 | Krainer Adrian R. · director | A-Award | 17,786 | $29 |
| Jun 5, 2026 | LEVIN ARTHUR A · director | A-Award | 17,786 | $29 |
| Jun 5, 2026 | Smith Julie · director | A-Award | 17,786 | $29 |
| Jun 5, 2026 | Kaye Edward M. MD · director | A-Award | 17,786 | $29 |
| Jun 5, 2026 | Harrison Seth Loring · director | A-Award | 17,786 | $29 |
| Jun 5, 2026 | Burstein Jennifer · director | A-Award | 17,786 | $29 |
| Jun 5, 2026 | TZIANABOS ARTHUR · director | A-Award | 17,786 | $29 |
| Jun 3, 2026 | Ticho Barry · officer: CHIEF MEDICAL OFFICER | Sale | 1,795 | $31 |
| May 5, 2026 | Ticho Barry · officer: CHIEF MEDICAL OFFICER | Sale | 2,243 | $33 |
| Apr 7, 2026 | Kahn Clare · director | A-Award | 30,782 | $33 |
| Apr 3, 2026 | Ticho Barry · officer: CHIEF MEDICAL OFFICER | Sale | 1,838 | $33 |
| Mar 24, 2026 | Allan Jonathan · officer: GENERAL COUNSEL & CORP SEC | Sale | 8,692 | $34 |
| Mar 24, 2026 | Allan Jonathan · officer: GENERAL COUNSEL & CORP SEC | Sale | 601 | $34 |
Institutional positioning
13F filings over the trailing two quarters
New 74Increased 155Reduced 115Sold out 29
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BlackRock, Inc. | Increased | 5,877,357 | Aug 7, 2026 |
| RTW INVESTMENTS, LP | Increased | 5,623,525 | May 15, 2026 |
| RTW INVESTMENTS, LP | Unchanged | 5,623,525 | Aug 14, 2026 |
| BLACKROCK, INC. | Increased | 5,385,714 | May 13, 2026 |
| FMR LLC | Reduced | 5,383,666 | May 15, 2026 |
| FMR LLC | Reduced | 5,313,100 | Aug 13, 2026 |
| LYNX1 CAPITAL MANAGEMENT LP | Reduced | 4,763,673 | May 4, 2026 |
| REDMILE GROUP, LLC | Increased | 4,164,120 | May 15, 2026 |
| Lynx1 Capital Management LP | Reduced | 4,038,404 | Aug 13, 2026 |
| Redmile Group, LLC | Reduced | 3,945,920 | Aug 14, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Increased | 3,519,301 | Aug 14, 2026 |
| MORGAN STANLEY | Increased | 3,452,795 | Aug 13, 2026 |
| MORGAN STANLEY | Reduced | 3,423,280 | May 15, 2026 |
| BAKER BROS. ADVISORS LP | Unchanged | 3,336,697 | May 15, 2026 |
| BAKER BROS. ADVISORS LP | Unchanged | 3,336,697 | Aug 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 3, 2026